Chronic kidney disease: The forgotten cardiovascular risk factor

International Journal of Clinical Practice

Volumn 63, Issue 6, 2009, Pages 964-965

  Barrios, V ^a   Escobar, C ^b   Echarri, R ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 6;

ALBUMIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LETTER; MAJOR CLINICAL STUDY; MALNUTRITION; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION;

CARDIOVASCULAR DISEASES; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 65649142145     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02059.x     Document Type: Letter

References (20)

1. Hakeem A, Bhatti S, Dillie KS et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 2008 118 : 2540 9.
2. Barrios V, Escobar C, Murga N et al. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice. J Hypertens 2008 26 : 2230 5.
3. Parekh RS, Plantinga LC, Kao WH et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 2008 74 : 1335 42.
4. Mancia G, De Backer G, Dominiczak A et al. Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 25 : 1105 87.
5. Schiele F. Renal dysfunction and coronary disease: a high-risk combination. J Nephrol 2009 22 : 39 45.
6. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004 351 : 1285 95.
7. Anavekar NS, Solomon SD, McMurray JJ et al. Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus. Am J Cardiol 2008 101 : 925 9.
8. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000 35 : 898 903.
9. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003 108 : 2154 69.
10. Vogt L, Navis G, Koster J et al. The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial. J Hypertens 2005 23 : 2055 61.
11. De Leeuw PW, Ruilope LM, Palmer CR et al. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. Arch Intern Med 2004 164 : 2459 64.
12. Escobar C, Echarri R, Barrios V. Combined therapy in the treatment of hypertension. But which? J Hypertens 2009 (in press).
13. Baigent C, Wheeler DC. Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure? Nephrol Dial Transplant 2000 15 : 1118 9.
14. Liu Y, Coresh J, Eustace JA et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 2004 291 : 451 9.
15. Lu B, Song X, Dong X et al. High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes Complicat 2008 22 : 96 103.
16. Yokoyama H, Sone H, Oishi M et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2009 24 : 1212 9.
17. New JP, Middleton RJ, Klebe B et al. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med 2007 24 : 364 9.
18. Rashidi A, Sehgal AR, Rahman M, O'Connor AS. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years. Am J Cardiol 2008 102 : 1668 73.
19. Graham I, Atar D, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007 28 : 2375 414.
20. Robles NR. Do we need glomerular filtration rate calculation? Int J Clin Pract 2007 61 : 1611 3.